Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01295944
Title Carboplatin and Bevacizumab for Recurrent Ependymoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital/Dana Farber Boston Massachusetts 02114 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field